Overview
Akinobu Hamada practices in Chuo, Japan. Hamada is rated as an Advanced expert by MediFind in the treatment of Triple-Negative Breast Cancer. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Triple-Negative Breast Cancer.
Their clinical research consists of co-authoring 131 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerHamada isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung CancerHamada isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Hamada isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Breast CancerHamada isAdvanced. Learn about Breast Cancer.
- Lung AdenocarcinomaHamada isAdvanced. Learn about Lung Adenocarcinoma.
- Peripheral NeuropathyHamada isAdvanced. Learn about Peripheral Neuropathy.
- Triple-Negative Breast Cancer
- Experienced
- Adult Soft Tissue SarcomaHamada isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaHamada isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Brain TumorHamada isExperienced. Learn about Brain Tumor.
- Chronic Myelogenous Leukemia (CML)
- Clear Cell SarcomaHamada isExperienced. Learn about Clear Cell Sarcoma.
- COVID-19Hamada isExperienced. Learn about COVID-19.